Journal for Healthcare Quality · 2023 · 51 citations · 21 references
PharmacyHealth Services AdministrationHealth Services ResearchHealthcare Quality ImprovementOutcomes ResearchClinical TrialsComparative Effectiveness AssessmentDeimplementationRandomized Comparative TrialsTreatment EffectivenessHealth Care EffectivenessHealth Service DeimplementationHealthcare PracticesLow-value Care ReductionValue-based Care Improvement
BACKGROUND: Low-value care is healthcare leading to no or little clinical benefit for the patient. The best (combinations of) interventions to reduce low-value care are unclear. PURPOSE: To provide an overview of randomized controlled trials (RCTs) evaluating deimplementation strategies, to quantify the effectiveness and describe different combinations of strategies. METHODS: Analysis of 121 RCTs (1990-2019) evaluating a strategy to reduce low-value care, identified by a systematic review. Deimplementation strategies were described and associations between strategy characteristics and effectiveness explored. RESULTS: Of 109 trials comparing deimplementation to usual care, 75 (69%) reported a significant reduction of low-value healthcare practices. Seventy-three trials included in a quantitative analysis showed a median relative reduction of 17% (IQR 7%-42%). The effectiveness of deimplementation strategies was not associated with the number and types of interventions applied. CONCLUSIONS AND IMPLICATIONS: Most deimplementation strategies achieved a considerable reduction of low-value care. We found no signs that a particular type or number of interventions works best for deimplementation. Future deimplementation studies should map relevant contextual factors, such as the workplace culture or economic factors. Interventions should be tailored to these factors and provide details regarding sustainability of the effect.
21
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page, Joanne E. McKenzie, Patrick M. Bossuyt et al. · BMJ · 2021 · 95K citations · Full text
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins, Doug Altman, Peter C Gøtzsche et al. · BMJ · 2011 · 34.2K citations · Full text
Greg Ogrinc, Louise Davies, Daisy Goodman et al. · BMJ Quality & Safety · 2015 · 2.8K citations · Full text
Health Professions, Health Services Administration, Quality Management +17